Please login to the form below

Not currently logged in
Email:
Password:

Graham Belgrave joins Cmed Clinical Sciences

He will take up the role of chief operations officer
Graham Belgrave

Cmed Clinical Services has appointed Graham Belgrave as its chief operations officer with a remit to manage the company's daily clinical operating activities.

He joins the UK-based firm from Grunenthal GmbH where he was senior vice president and global head of clinical development, science and operations.

During his 30 year career in the pharmaceutical industry, Belgrave has held positions at GSK, Pfizer and Vernalis as well as working in consultancy and interim management positions, including for Roche's oncology portfolio.

Dr David Connelly, Cmed's chief executive officer, said: “Graham has a great track record over many years in the pharmaceutical industry and his breadth of clinical development experience across many therapy areas in phases I-IV combined with his strong leadership skills will complement and strengthen our existing senior management team.

“He will be a valuable asset to Cmed as we continue to drive growth.”

16th January 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics